The Unmet Need in Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD) is a chronic, unpredictable, inflammatory disorder of the digestive tract with major clinical and economic burden. Treatment guidelines have recently been updated with new long-term goals for the management of IBD. However, there is a need to address clinical advances with a focus on long-term patient outcomes. The objective of this webinar is to review IBD, treatment guidelines, clinical decision making and the associated economic burden.

Background:

• An estimated 3 million Americans suffer from IBD.²
• The prevalence of IBD is higher in the US than any other country in the world and is increasing.¹
• IBD damages the bowel and may result in decreased quality of life, hospitalizations, surgeries, and Increased healthcare costs.
• 25-40% of IBD patients may develop an extra-intestinal manifestation.³
• Up to 25% of IBD patients have more than one EIM.³
• IBD symptoms are often unpredictable and are associated with a considerable clinical and economic burden.²

Learning Objectives:

• Discuss the epidemiology of IBD and the associated clinical burden that often requires multiple treatment options for patients.
• Review the AGA Guidelines and the Treat to Target approach from the STRIDE-II recommendations discussing the impact of disease progression, long-term outcomes, and economic considerations of the early use of advanced treatment options.

Speaker:

Casey Chapman, MD
Chief Medical Officer
GI Alliance
Clinical Assistant Professor of Medicine/Gastroenterology
Louisiana State University

This webinar is sponsored, developed, and presented by the sponsor.  The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

AbbVie US Medical Affairs

Registration is free for Members and Non-Members

For individuals from the media/press interested in attending, please email media@amcp.org.

REGISTER TODAY

1. IBD 2017 Inflammatory Bowel Disease Collaborators. Lancet Gastroenterol Hepatol 2020;5(1):17-30
2. Crohn's and Colitis Foundation accessed online 8/16/2021 at https://www.crohnscolitisfoundation.org/what-is-crohns-disease/causes
3. Levine JS and Burakoff R. Gastroenterol Hepatol 2011;7(4): 235-41